Drug Profile
Ciglitazone
Alternative Names: ADD 3878; U 63287Latest Information Update: 13 Jul 1995
Price :
$50
*
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Antihypertensives; Small molecules; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 24 Nov 1994 Discontinued-II for Diabetes mellitus in Japan (PO)